Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Tetanus and diphtheria toxoids (Td) adsorbed when administered to individuals 7 years or older, for intramuscular use

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 90718 refers to the administration of tetanus and diphtheria toxoids (Td) that are adsorbed, specifically designed for individuals aged 7 years and older. Toxoids are inactivated toxins produced by bacteria, which are used in vaccines to stimulate the immune system. By introducing these altered forms of toxins into the body, the immune system is prompted to produce antibodies that can effectively neutralize the specific toxins if encountered in the future. This process results in long-lasting immunity, as the body retains a memory of how to produce these antibodies upon subsequent exposures to the same pathogens. The Td vaccine is administered via intramuscular injection, making it a straightforward and effective method for immunization. It is important to note that since toxoids are not live vaccines, booster doses are necessary to maintain immunity over time, as the protective effects can diminish. The Td vaccine is particularly relevant for adults and older children, ensuring they are protected against the serious diseases caused by tetanus and diphtheria. Additionally, related codes such as 90715 and 90714 pertain to other formulations of tetanus and diphtheria vaccines, including combinations with acellular pertussis, highlighting the variety of immunization options available to healthcare providers.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The tetanus and diphtheria toxoids (Td) vaccine is indicated for individuals aged 7 years and older. The primary purpose of administering this vaccine is to provide protection against the diseases caused by the toxins produced by the bacteria responsible for tetanus and diphtheria. The following conditions warrant the administration of the Td vaccine:

  • Prevention of Tetanus Tetanus is a serious bacterial infection characterized by muscle stiffness and spasms, which can lead to severe complications and even death.
  • Prevention of Diphtheria Diphtheria is a potentially fatal respiratory disease caused by the diphtheria toxin, leading to severe throat inflammation and systemic complications.
  • Booster Immunization Individuals who have previously received the vaccine may require booster doses to maintain immunity, especially if they have not been vaccinated in the last ten years.

2. Procedure

The administration of the Td vaccine involves several key procedural steps to ensure safety and efficacy. The following steps outline the process:

  • Step 1: Patient Assessment Prior to vaccination, the healthcare provider must assess the patient's medical history, including any previous vaccinations, allergies, and current health status to determine the appropriateness of the Td vaccine.
  • Step 2: Preparation of the Vaccine The Td vaccine is prepared according to the manufacturer's guidelines. This includes checking the expiration date, ensuring the vaccine is stored at the correct temperature, and shaking the vial gently to mix the contents if necessary.
  • Step 3: Site Selection and Preparation The healthcare provider selects an appropriate intramuscular injection site, typically the deltoid muscle in the upper arm for adults and older children. The site is then cleaned with an antiseptic wipe to reduce the risk of infection.
  • Step 4: Administration of the Vaccine The vaccine is administered via intramuscular injection using a sterile needle and syringe. The provider should inject the vaccine at a 90-degree angle to ensure proper delivery into the muscle.
  • Step 5: Post-Administration Care After the injection, the healthcare provider monitors the patient for any immediate adverse reactions, providing guidance on potential side effects and the importance of follow-up vaccinations as needed.

3. Post-Procedure

Following the administration of the Td vaccine, patients are typically advised to remain in the healthcare setting for a short period to monitor for any immediate allergic reactions. Common post-procedure care includes advising patients to apply a cool compress to the injection site to alleviate any discomfort or swelling. Patients may experience mild side effects such as soreness at the injection site, low-grade fever, or fatigue, which usually resolve within a few days. It is important for patients to be informed about the need for booster doses every ten years to maintain immunity against tetanus and diphtheria. Additionally, patients should be encouraged to report any unusual or severe reactions to their healthcare provider promptly.

Short Descr TD VACCINE > 7 IM
Medium Descr TETANUS & DIPHTHERIA TOXOIDS ADSORBED 7/>YR IM
Long Descr Tetanus and diphtheria toxoids (Td) adsorbed when administered to individuals 7 years or older, for intramuscular use
Related Drugs TENIVAC
Status Code Excluded from Physician Fee Schedule by Regulation
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator Discontinued Code
Type of Service (TOS) 1 - Medical Care
Berenson-Eggers TOS (BETOS) O1G - Immunizations/Vaccinations
MUE Not applicable/unspecified.
CCS Clinical Classification 228 - Prophylactic vaccinations and inoculations
Date
Action
Notes
2013-01-01 Deleted Code deleted
2011-01-01 Changed Short description changed.
2008-01-01 Changed Code description changed.
2007-01-01 Changed Code description changed.
2005-01-01 Changed Code description changed.
2004-01-01 Changed Code description changed.
2001-01-01 Changed Code description changed.
Pre-1990 Added Code added.
Code
Description
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"